8
Views
2
CrossRef citations to date
0
Altmetric
Research Article

The sensitivity of urinary isolates to cefuroxime, a new β-lactamase stable cephalosporin

, , &
Pages 5-13 | Received 25 May 1980, Published online: 11 Aug 2008
 

Summary

The sensitivities to cefuroxime and cephaloridine were compared in 500 bacterial isolates from consecutive cases of urinary tract infection. In thefirst 200 organisms there was generally good correlation between the diameters of the zone of inhibition around a 30 μg cefuroxime disc and the MICs. Correlation was poorest with streptococci. From the preliminary observations, criteria were derived to relate the disc sensitivities to MICs for all 500 strains. Neither cephalosporin had significant activity against Pseudomonas spp. but, apart from one strain of Klebsiella and one rnethicillin-resistant staphylococcus, the only bacteria sensitive to cephaloridine but resistant to cefuroxime were Str. faecalis. Of the 500 organisms, 45% were β-lactamase-producing Gram-negative bacilli and, overall, cefuroxime was more active than cephaloridine against them. The greater stability of cefuroxime to the β-lactamases from these bacilli were also supported by a smaller increase in MIC when the inoculum size was increased. On the basis of these results, cefuroxime should prove an effective choice for the treatment of most urinary tract infections.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.